Navigation Links
Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Prescription Drugs market. The global prescription drugs market is witnessing a significant deceleration in growth. Key factors slowing down growth in the global prescription drugs market include economic downturn, increasing number of drugs going off patent, increasing proliferation of generics, falling drug costs, and fewer new drug approvals. On the positive side, the market is experiencing increased demand for biologics, biopharmaceuticals, and pharmacogenomics, which are spearheading growth in the industry.

San Jose, CA (PRWEB) June 30, 2009 -- Global Prescription Drugs market is projected to cross US$897 billion by 2015. The pharmaceutical industry is also witnessing the effects of the global economic downturn. Various governments worldwide are embarking on cost containment measures, resulting in increased pricing pressures. However, compared to any other industry, the pharmaceutical industry is relatively shielded from economic cycles, as consumer spending on drugs is out of compulsion rather than discretionary spending as in most other industries. As such, sales of pharmaceuticals are expected to slowdown in 2009 and 2010, with declines or flat growth expected in mature markets such as the US, Japan, and Western Europe. The effects of the global economic downturn are expected to vary in different markets owing to the differences in respective market characteristics.

The global prescription drugs market is currently witnessing, and would further witness, a shift in terms of market growth from matured markets towards emerging markets. Patent expiries of major drugs, and subsequent entry of generics that are priced lower, increasing pressure to contain costs, along with increased healthcare legislation and safety scrutiny are slowing down growth in major markets. On the other hand, improved access to innovative and generic medicines, as a result of growth and geographical expansion in primary care, and growing popularity of private health insurance is driving growth in emerging markets such as Brazil, Russia, India, China, South Korea, Mexico and Turkey.

The United States represents the largest market for prescription drugs worldwide. Asia-Pacific region is expected to offer the highest growth potential for prescription drugs over the period 2006-2015. Oncologics/Cancer Drugs market is the largest and the fastest growing prescription drug therapeutic class. Respiratory Agents market represents the second largest therapeutic class in 2009, followed closely by Lipid Regulators market. However, owing to a spate of patent expiries, including that of Lipitor - the largest selling drug, lipid regulators are expected to witness a decline in revenues, and share of the global prescription drugs market.

These and other market data and trends are presented in "Prescription Drugs: A Global Strategic Business Report" announced by Global Industry Analysts, Inc. This GIA report discusses the prevailing trends, issues, demand forecasts, and activities that affect the industry. Detailed discussions on leading drugs by therapeutic class, patent expiries of major drugs, review of pipeline drugs, and M&A activity in the industry give a holistic view of the global and regional prescription drugs markets. The global prescription drugs market is analyzed by revenues in US$ Billion. The global market is analyzed further by the following therapeutic classes/ categories - Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors, Antidiabetics, Antipsychotics, Antidepressants, Angiotensin II Antagonists, Anti-Epileptics, Autoimmune Agents, and Others. Major regional markets analyzed in the report include USA, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Analytics for the period 2006-2015 provide a comprehensive understanding of the market. Additionally, historic review is provided for the period 2001 to 2005.

Global players profiled in the report include Pfizer, Glaxosmithkline, Novartis, Sanofi-Aventis, Astrazeneca, Roche, Johnson & Johnson, Merck & Co., Abbott, Eli Lilly, Amgen, Wyeth, Teva, Bayer, Takeda, and others. The study enumerates recent developments, mergers, acquisitions, and other strategic industry activities, and is an easy guide to What, Why, When, How, Where, and Who of the industry.

For more details about this comprehensive market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press (at) StrategyR (dot) com
Web Site


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes
2. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
3. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
4. deCODE Reinstated to Nasdaq Global Market
5. BIO Ventures for Global Health Announces Management Changes
6. World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
7. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
8. Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels
9. BD and FIND Achieve Milestone in Global Battle Against MDR-TB
10. Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing
11. Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index
Post Your Comments:
Related Image:
Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
(Date:11/24/2015)... ... November 24, 2015 , ... The Academy of Model Aeronautics (AMA), led ... also known as Multirotor Grand Prix, to represent the First–Person View (FPV) racing community. ... members have embraced this type of racing and several new model aviation pilots have ...
(Date:11/24/2015)... Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of ... Israel time, at the law offices of Goldfarb ... Floor, Tel Aviv, Israel . ... Tamir to the Board of Directors; , election of ... of an amendment to certain terms of options granted to our Chief ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... are paramount. Insertion points for in-line sensors can represent a weak spot where ... InTrac 781/784 series of retractable sensor housings , which are designed to tolerate ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW Telbec/ - ProMetic Life ... announced today that Mr. Pierre Laurin , President and ... presentation at the upcoming Piper Jaffray 27 th Annual ... Hotel, on December 1-2, 2015. st , ... for one-on-one meetings throughout the day. The presentation will be ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/9/2015)... 09, 2015 ... the "Global Law Enforcement Biometrics Market ... --> ) has announced the ... Biometrics Market 2015-2019" report to their ... ( ) has announced the addition ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
Breaking Biology News(10 mins):